To evaluate whether the pretreatment apparent diffusion coefficient (ADC) heterogeneity parameters and their alterations, after one cycle of induction chemotherapy, can be used as reliable markers of treatment response to induction chemotherapy in patients with nasopharyngeal cancer.
Materials and methods
Ten patients were recruited and received induction chemotherapy (IC). Diffusion-weighted imaging was performed prior to, during, and after IC. The first-order ADC histogram parameters at the intra-treatment time-point were compared to the baseline time-point in the metastatic lymph nodes (LNs). Some ADC pretreatment parameters were combined with each other, employing discriminant analysis to achieve a feasible model to separate the complete response (CR) from the partial response (PR) groups.
For ten patients, significant rise in Mean and Txt1Mean (p = 0.048 and 0.015, respectively) was observed in the metastatic nodes following one cycle of IC. Txt5Energy significantly decreased (p = 0.002). Discriminant analysis on pretreatment parameters illustrated that Txt5Energypre was the best parameter to use to correctly classify CR and PR patients. This was followed by Txt9Percentile75pre, Txt1Meanpre, and Txt2Standard Deviationpre.
Our results suggest that heterogeneity metrics extracted from ADC-maps in metastatic lymph nodes, before and after IC, can be used as supplementary IC response indicators.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Wei WI, Sham JS (2005) Nasopharyngeal carcinoma. The Lancet 365(9476):2041–2054
Hatakenaka M, Nakrumara K, Yabuchi H et al (2011) Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol* Biol* Phy 81(2):339–345
Matoba M, Tuji H, Shimode Y et al (2014) Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy. Am J Neuroradiol 35(2):379–385
Powell C, Schmidth M, Marco B et al (2013) Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer. Radiother Oncol 106(1):112–117
Lee KC, Moffat B, Schott A et al (2007) Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy. Clin Cancer Res 13(2):443–450
Vandecaveye V, Dirix P, De kazer F et al (2012) Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma. Int J Radiat Oncol* Biol* Phy 82(3):1098–1107
Yoon DY, Hwang H, Chang S et al (2009) CT, MR, US, 18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol 19(3):634–642
Ali TFT (2012) Neck lymph nodes: characterization with diffusion-weighted MRI. Egypt J Radiol Nucl Med 43(2):173–181
Eisenhauer E, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247
King AD, Ahuja A, Yeung D et al (2007) Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology 245(3):806–813
Hoang JK, Choudhury KR, Chang J, Craciunescu OI, Yoo DS, Brizel David M et al (2014) Diffusion-weighted imaging for head and neck squamous cell carcinoma: quantifying repeatability to understand early treatment-induced change. Am J Roentgenol 203(5):1104–1108
Lee MC, Tsai HY, Chung KS, Chen MK et al (2013) Prediction of nodal metastasis in head and neck cancer using a 3T MRI ADC map. Am J Neuroradiol 34(4):864–869
Kim S, Loevner L, Quon H et al (2009) Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 15(3):986–994
Chawla S et al (2013) Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck. AJR Am J Roentgenol 200(1):35
Chen Y, Liu X, Zheng D et al (2014) Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma. Magn Reson Imaging 32(6):630–637
Ohgiya Y, Suyama J, Seino N et al (2010) MRI of the neck at 3 Tesla using the periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER)(BLADE) sequence compared with T2-weighted fast spin-echo sequence. J Magn Reson Imaging 32(5):1061–1067
This work was fully supported by a Grant from the Shahid Beheshti University of Medical Science (Grant number: 5232), Tehran, Iran. We are extremely grateful to Ms Aramesh Safari and Mr Pedram Rostami for providing imaging data in Payambaran MRI center. Also, we would like to thank Clinical Research Development Center in Imam Hosein Hospital for highly contributing to the progression of this project.
This study was funded by Grant number 5232.
Conflict of interest
The authors declare no conflict of interest
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
About this article
Cite this article
Beigi, M., Kazerooni, A.F., Safari, M. et al. Heterogeneity analysis of diffusion-weighted MRI for prediction and assessment of microstructural changes early after one cycle of induction chemotherapy in nasopharyngeal cancer patients. Radiol med 123, 36–43 (2018). https://doi.org/10.1007/s11547-017-0808-9
- Nasopharyngeal cancer
- Lymph node
- Induction chemotherapy
- Diffusion-weighted MRI